Shawn Beckemeyer
Family Medicine · Coulterville, ILNPI 1023075264
Payments from drug & device makers
Across 115 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$289
- Novo Nordisk$277
- AbbVie$248
- Amgen$188
- Boehringer Ingelheim$161
- Exact Sciences$142
- plus $635 from 16 others
What the payments were for
- Food & beverage$1,91098%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $289 |
| Novo Nordisk | 16 | $277 |
| AbbVie(2 entities) | 13 | $248 |
| Amgen | 11 | $188 |
| Boehringer Ingelheim | 11 | $161 |
| Exact Sciences | 7 | $142 |
| Dexcom, Inc. | 8 | $120 |
| AstraZeneca | 6 | $96 |
| Pfizer | 3 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $64 |
| GSK | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Johnson & Johnson | 2 | $26 |
| Bayer | 1 | $26 |
| Merck | 2 | $25 |
| Organon | 1 | $24 |
| Novartis | 2 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $11 |
How this compares
$1,940 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $87,482 |
| TrulicityDulaglutide | 56 | $58,729 |
| MounjaroTirzepatide | 53 | $57,550 |
| EliquisApixaban | 47 | $47,785 |
| JardianceEmpagliflozin | 56 | $43,256 |
| XareltoRivaroxaban | 14 | $21,169 |
| Spiriva RespimatTiotropium Bromide | 20 | $11,188 |
| LinzessLinaclotide | 11 | $9,189 |
| Spiriva HandihalerTiotropium Bromide | 15 | $7,305 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $7,070 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,731 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $3,903 |
| Gabapentin | 236 | $3,617 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 93 | $2,998 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $2,997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $289 | $116,279109 claims |
| Novo NordiskOzempic | $277 | $87,48265 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $161 | $54,44476 claims |
| PfizerEliquis | $78 | $47,78547 claims |
| Johnson & JohnsonXarelto | $26 | $21,16914 claims |
| AbbVieLinzess, Synthroid | $248 | $10,49724 claims |
| GSKBreo Ellipta | $57 | $5,73114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Coulterville
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.